Rockefeller Capital Management L.P. Moleculin Biotech, Inc. Transaction History

Rockefeller Capital Management L.P.

  • $34.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.19 - $2.0 $1,172 - $1,970
-985 Reduced 35.47%
1,792 $2,000
Q3 2021

Nov 12, 2021
SELL
$2.7 - $3.59 $518 - $689
-192 Reduced 6.47%
2,777 $8,000
Q1 2021

May 11, 2021
BUY
$3.7 - $6.42 $10,985 - $19,060
2,969 New
2,969 $12,000

Others Institutions Holding MBRX

# of Institutions
2
Shares Held
3.35K
Call Options Held
0
Put Options Held
0
View Full List

About Moleculin Biotech, Inc.

MBRX Quotes by TradingView
  • Ticker MBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,606,700
  • Market Cap $67.5M
  • Description
  • Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....
More about MBRX
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email